Investors | Novartis

We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.

First quarter results 2023

April 25, 2023 | Basel, Switzerland

Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)

Condensed financial report (PDF 0.3 MB)

Watch the webcast

Download the podcast (MP3 34 MB)

Download the interactive presentation (PDF 3.4 MB)

Read the presentation transcript

Novartis Q1 2023 Impact and Sustainability Update (PDF 1.9 MB)

Learn more

Walkway at the entrance of the Novartis Campus in Basel, Switzerland

Investors Event Calendar

View recent presentations and learn more about upcoming events.

June 04, 2023
ASCO Investor Event
Chicago, USA

Learn more

Van Lacour, prostate cancer patient living in Natchez, Louisiana, who received a Novartis radioligand therapy

Novartis Annual Reporting Suite

Read and download our integrated report, annual regulatory filings, and other disclosures.

Learn more

Environmental, Social and Governance (ESG)

Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.

Learn more

ESG Updates: May 03, 2023 (PDF 1.9 MB) | Feb 06, 2023 (PDF 0.9 MB) | Oct 31, 2022 (PDF 0.5 MB) | July 20, 2022 (PDF 0.4 MB)
Latest updates: Investor Update on Access & Sustainability (PDF 1.6 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB) | Materiality Assessment

We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.

Explore the ESG indices

Stocks